[go: up one dir, main page]

MX2013011930A - Cepa de lactobacillus paracasei ncc2461 (st11) para ser usada en la administracion perinatal materna en la reduccion y la prevencion de las alergias en la progenie. - Google Patents

Cepa de lactobacillus paracasei ncc2461 (st11) para ser usada en la administracion perinatal materna en la reduccion y la prevencion de las alergias en la progenie.

Info

Publication number
MX2013011930A
MX2013011930A MX2013011930A MX2013011930A MX2013011930A MX 2013011930 A MX2013011930 A MX 2013011930A MX 2013011930 A MX2013011930 A MX 2013011930A MX 2013011930 A MX2013011930 A MX 2013011930A MX 2013011930 A MX2013011930 A MX 2013011930A
Authority
MX
Mexico
Prior art keywords
progeny
prevention
reduction
lactobacillus paracasei
allergies
Prior art date
Application number
MX2013011930A
Other languages
English (en)
Inventor
Annick Mercenier
Adrian Zuercher
Sophie Nutten
Ursula Wiedermann
Irma Schabussova
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013011930A publication Critical patent/MX2013011930A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención proporciona un probiótico Lactobacillus paracasei NCC 2461, es decir ST1 1, para ser usado mediante administración a hembras embarazadas y/o madres en periodos de lactancia, y para su progenie para la reducción o prevención del desarrollo de respuestas inmunes alérgicas en la progenie. Una dosis diaria de ST1 1 se administra a una mujer embarazada por al menos 2 semanas antes del parto y luego del parto la dosis diaria de ST1 1 se administra a la madre en periodo de lactancia o el lactante recién nacido por al menos dos meses, ya sea directamente o través de la leche materna. Las respuestas inmunes del lactante a los alérgenos entonces se ven reducidas, resultando en una respuesta alérgica "reducida". Por lo tanto la alergia incluyendo la atopia puede ser prevenida en la progenie.
MX2013011930A 2011-04-15 2012-04-11 Cepa de lactobacillus paracasei ncc2461 (st11) para ser usada en la administracion perinatal materna en la reduccion y la prevencion de las alergias en la progenie. MX2013011930A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11162632A EP2510932A1 (en) 2011-04-15 2011-04-15 Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
PCT/EP2012/056503 WO2012140031A1 (en) 2011-04-15 2012-04-11 Lactobacillus paracasei ncc2461 (st11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny

Publications (1)

Publication Number Publication Date
MX2013011930A true MX2013011930A (es) 2014-05-27

Family

ID=44209952

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013011930A MX2013011930A (es) 2011-04-15 2012-04-11 Cepa de lactobacillus paracasei ncc2461 (st11) para ser usada en la administracion perinatal materna en la reduccion y la prevencion de las alergias en la progenie.

Country Status (12)

Country Link
EP (2) EP2510932A1 (es)
CN (1) CN103826648A (es)
AU (1) AU2012241904A1 (es)
BR (1) BR112013025833A2 (es)
CA (1) CA2829261A1 (es)
CL (1) CL2013002733A1 (es)
MX (1) MX2013011930A (es)
PH (1) PH12013501740A1 (es)
RU (1) RU2013150838A (es)
SG (1) SG193911A1 (es)
WO (1) WO2012140031A1 (es)
ZA (1) ZA201308584B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3366143T3 (da) 2011-06-20 2025-01-27 Heinz Co Brands H J Llc Probiotiske sammensætninger og fremgangsmåder
PT2861242T (pt) 2012-06-18 2018-11-07 Heinz Co Brands H J Llc Disfunções relacionadas com o glúten
PL3470074T3 (pl) 2013-05-10 2021-04-06 H.J. Heinz Company Brands Llc Probiotyki
WO2015090349A1 (en) * 2013-12-16 2015-06-25 Nestec S.A. Probiotic nutritional intervention during pregnancy and optionally lactation to reduce risk of allergy in infants
WO2016013928A1 (en) 2014-07-24 2016-01-28 N.V. Nutricia Prevention or treatment of food allergy in infants and toddlers
IT201800004072A1 (it) * 2018-03-29 2019-09-29 Smart Farma S R L Composizione alimentare come coadiuvante nello sviluppo della microflora intestinale e del sistema immunitario dei neonati
CN110892990B (zh) * 2019-10-11 2023-03-31 内蒙古伊利实业集团股份有限公司 益生菌益生元食用组合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
FI110668B (fi) 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
FR2876029B1 (fr) * 2004-10-04 2008-11-14 Oreal Composition cosmetique et/ou dermatologique pour peaux sensibles.
EP1964570B1 (de) * 2007-03-02 2012-11-21 Protectimmun GmbH Pharmazeutische Zusammensetzung zum Schutz vor Allergien und entzündlichen Erkrankungen
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP2100604B1 (en) * 2008-03-10 2012-07-04 Nestec S.A. Medium chain dicarboxylic acids and their derivates and metabolic disorders
ES2550499T3 (es) 2008-03-28 2015-11-10 Nestec S.A. Probióticos de uso en mamíferos hembra gestantes para aumentar la inmunidad de sus crías
CN102695427B (zh) * 2009-08-18 2016-04-13 雀巢产品技术援助有限公司 包含乳球菌属菌株并且特别是在婴儿和儿童中减少过敏症状的营养组合物

Also Published As

Publication number Publication date
PH12013501740A1 (en) 2013-11-18
RU2013150838A (ru) 2015-05-20
AU2012241904A1 (en) 2013-09-12
ZA201308584B (en) 2015-06-24
CA2829261A1 (en) 2012-10-18
CN103826648A (zh) 2014-05-28
CL2013002733A1 (es) 2014-07-11
WO2012140031A1 (en) 2012-10-18
EP2510932A1 (en) 2012-10-17
EP2696880A1 (en) 2014-02-19
SG193911A1 (en) 2013-11-29
BR112013025833A2 (pt) 2016-12-20

Similar Documents

Publication Publication Date Title
PH12013501740A1 (en) Lactobacillus paracasei ncc2461 (st11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
RU2012110170A (ru) ПИТАТЕЛЬНАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ШТАММЫ Bifidobacterium longum И ОСЛАБЛЯЮЩАЯ СИМПТОМЫ ПИЩЕВОЙ АЛЛЕРГИИ, ОСОБЕННО У МЛАДЕНЦЕВ И ДЕТЕЙ
Committee on Health Care for Underserved Women ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects
PH12013501920A1 (en) Methods for improving bone health in infants using prebiotics
MY165628A (en) Human milk oligosaccharides for modulating inflammation
CN105124356A (zh) 一种改善孕产妇贫血、便秘、腰腿酸痛的营养包
MY177636A (en) Use of lactic acid bacteria to treat or prevent eczema
MX385648B (es) Composiciones nutritivas y formulas infantiles que comprenden bifidobacterium animalis ssp.lactis y, opcionalmente, una mezcla de oligosacaridos para inducir una microbiota intestinal cercana a la de un infante alimentado por lactancia materna.
PH12020550463A1 (en) Human milk fortifier composition
MX2016006503A (es) Formulacion de bifidobacterium lactis ncc 2818 tratada con calor que reduce las manifestaciones alergicas.
PH12012502526A1 (en) Early programming of brain function through soy protein feeding
MX2021006186A (es) Composicion fortificadora de leche humana.
MX2020001840A (es) Administracion de vitamina b2 materna para la prevencion del aumento de la adiposidad, el sobrepeso o la obesidad en la descendencia.
Dastgerdi et al. Effect of metoclopramide on increased milk production in mothers of preterm infants
CN202222872U (zh) 母子被套
MX2019015889A (es) Administracion de vitamina b6 materna para la prevencion del aumento de la adiposidad, el sobrepeso a la obesidad en la descendencia.
MX2015004577A (es) Suplemento nutricional para pacientes con enfermedades reumaticas.
CN203735893U (zh) 多功能哺乳被
CN203776538U (zh) 多功能孕妇枕
CN205358322U (zh) 一种漏斗式护膝
CN203194620U (zh) 一种会阴防护裤
CN202589726U (zh) 肩部约束带
Jin et al. Micronutrient intake and supplement usage of pregnant and lactating women in New Zealand
CN103550524B (zh) 一种治疗小儿痉挛型脑性瘫痪的药剂
MX2022002064A (es) Mioinositol y la prevencion del parto prematuro.